3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
281
Head and Neck Neoplasms
258
Nasopharyngeal Carcinoma
127
Oropharyngeal Neoplasms
57
Carcinoma, Squamous Cell
54
Nasopharyngeal Neoplasms
41
Laryngeal Neoplasms
35
Mouth Neoplasms
30
Hypopharyngeal Neoplasms
29
Carcinoma
24
Salivary Gland Neoplasms
19
Carcinoma, Non-Small-Cell Lung
16
Tongue Neoplasms
15
Neoplasm Metastasis
13
Laryngeal Diseases
13
Recurrence
12
Neoplasms
10
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Mucositis
8
Stomach Neoplasms
7
Pharyngeal Neoplasms
7
Papillomavirus Infections
7
Ovarian Neoplasms
7
Lung Neoplasms
7
Radiation Injuries
6
Pancreatic Neoplasms
6
Neoplasms, Squamous Cell
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Thyroid Neoplasms
5
Interventions
Radiotherapy, Intensity-Modulated
1
Oncolytic Virotherapy
1
Nimorazole
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Virus Diseases
×
Cisplatin
×
Head & Neck
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled